Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus

BACKGROUND: Tacrolimus is the key immunosuppressive drug for liver transplantation. Once-daily prolonged-release tacrolimus (TAC-PR) exhibits good drug adherence but has difficulty controlling the trough level in the early phase of liver transplantation. The aim of this study was to compare the feas...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transplant Direct
Egile Nagusiak: Okumura, Yuichiro, Noda, Takehiro, Eguchi, Hidetoshi, Iwagami, Yoshifumi, Yamada, Daisaku, Asaoka, Tadafumi, Wada, Hiroshi, Kawamoto, Koichi, Gotoh, Kunihito, Takeda, Yutaka, Tanemura, Masahiro, Marubashi, Shigeru, Umeshita, Koji, Doki, Yuichiro, Mori, Masaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2017
Gaiak:
Liver Transplantation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5585423/
https://ncbi.nlm.nih.gov/pubmed/28894794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000722
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak